Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 22,000 shares, a growth of 185.7% from the March 31st total of 7,700 shares. Based on an average trading volume of 3,178,000 shares, the short-interest ratio is presently 0.0 days.
Reckitt Benckiser Group Stock Performance
Shares of OTCMKTS RBGLY traded up $0.10 during mid-day trading on Friday, hitting $11.10. 757,213 shares of the stock were exchanged, compared to its average volume of 1,077,789. The stock's fifty day simple moving average is $12.00 and its two-hundred day simple moving average is $13.26. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $16.60.
Reckitt Benckiser Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Monday, June 3rd. Stockholders of record on Friday, April 12th will be issued a dividend of $0.2701 per share. This is a positive change from Reckitt Benckiser Group's previous dividend of $0.18. The ex-dividend date is Thursday, April 11th.
Analyst Upgrades and Downgrades
Separately, BNP Paribas upgraded shares of Reckitt Benckiser Group from an "underperform" rating to a "neutral" rating in a research note on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Reckitt Benckiser Group presently has an average rating of "Hold" and an average price target of $6,978.00.
Read Our Latest Stock Analysis on RBGLY
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
